NU students have developed a test to detect early signs of Alzheimer’s disease

The myMind test, developed by NU graduates and Technopark resident, helps to detect early signs of Alzheimer’s. According to the developers, the technology will allow timely detection of the disease. The test is an analysis of cognitive functions such as thinking, spatial orientation, comprehension, learning, speech, and reasoning ability. All these factors help to learn more information about possible symptoms, risks, causes, consequences, and preventive measures.

“By identifying the need for professional medical care, the test saves patients’ time and money, since preliminary diagnostics in medical institutions can be more complicated and expensive,” said one of the project developers Amanzhol Shungeyev, School of Engineering and Digital Sciences graduate.

The myMind test is the brainchild of iDala team, NURIS Technopark resident ‘IHT Central Asia’, and researchers from the Universal Brain Centre headed by Zhibek Zholdassova, MD, a psychotherapist with over 25 years of experience working with patients with Alzheimer’s syndrome. Project mentor – Seitzhan Sypabekov, entrepreneur, graduate of the Medical Academy and Doctor of Business Administration DBA EU Business School (Switzerland). The content of the test and a detailed interpretation of all the results will be in Kazakh, Russian, and English. Today, the developers are working on improving the product. Soon it will be available to everyone on a paid basis.

Last year, the iDala team developed a smart test that assesses the probability of contracting COVID-19. Its principle is based on an artificial intelligence technology known as a neural network.